Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Martin

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
Molecular Immunology|July 1, 1983
Immunochemistry of scorpion alpha-neurotoxins. Determination of the antigenic site number and isolation of a highly enriched antibody specific to a single antigenic site of toxin II of Androctonus australis HectorM El Ayeb, M F Martin, P Delori, et al.
International Journal of Peptide and Protein Research|February 1, 1987
Amino acid sequence of toxin XI of the scorpion Buthus occitanus tunetanus. Evidence of a mutation having an important effect upon neurotoxic activityF Sampieri, C Habersetzer-Rochat, M F Martin, et al.
The British Journal of Ophthalmology|October 13, 2001
Bilateral facial nerve palsy associated with p-ANCA positive vasculitis in a patient with rheumatoid arthritisO G Stewart, I G Simmons, M F Martin, et al.
Biochemical and Biophysical Research Communications|August 29, 1986
Tityus serrulatus toxin VII bears pharmacological properties of both beta-toxin and insect toxin from scorpion venomsM E De Lima, M F Martin, C R Diniz, et al.
FEBS Letters|April 12, 1993
Characterization of a new leiurotoxin I-like scorpion toxin. PO5 from Androctonus mauretanicus mauretanicusH Zerrouk, P Mansuelle, A Benslimane, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|March 13, 2003
Covalent structure and some pharmacological features of native and cleaved alpha-KTx12-1, a four disulfide-bridged toxin from Tityus serrulatus venomA M C Pimenta, P Mansuelle, C R Diniz, et al.
Journal De Physiologie|January 1, 1984
Interaction of scorpion toxins with the sodium channelH Rochat, H Darbon, E Jover, et al.
The Journal of Rheumatology|August 1, 1992
Systemic lupus erythematosus presenting with myelofibrosisD Foley-Nolan, M F Martin, D Rowbotham, et al.
International Journal of Clinical Pharmacology Research|January 1, 1985
Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel antirheumatoid drugsJ S Dixon, H A Bird, M F Martin, et al.
British Journal of Rheumatology|October 1, 1988
The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapyT Pullar, S Peaker, M F Martin, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Molecular Immunology|July 1, 1983
Immunochemistry of scorpion alpha-neurotoxins. Determination of the antigenic site number and isolation of a highly enriched antibody specific to a single antigenic site of toxin II of Androctonus australis HectorM El Ayeb, M F Martin, P Delori, et al.
International Journal of Peptide and Protein Research|February 1, 1987
Amino acid sequence of toxin XI of the scorpion Buthus occitanus tunetanus. Evidence of a mutation having an important effect upon neurotoxic activityF Sampieri, C Habersetzer-Rochat, M F Martin, et al.
The British Journal of Ophthalmology|October 13, 2001
Bilateral facial nerve palsy associated with p-ANCA positive vasculitis in a patient with rheumatoid arthritisO G Stewart, I G Simmons, M F Martin, et al.
Biochemical and Biophysical Research Communications|August 29, 1986
Tityus serrulatus toxin VII bears pharmacological properties of both beta-toxin and insect toxin from scorpion venomsM E De Lima, M F Martin, C R Diniz, et al.
FEBS Letters|April 12, 1993
Characterization of a new leiurotoxin I-like scorpion toxin. PO5 from Androctonus mauretanicus mauretanicusH Zerrouk, P Mansuelle, A Benslimane, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|March 13, 2003
Covalent structure and some pharmacological features of native and cleaved alpha-KTx12-1, a four disulfide-bridged toxin from Tityus serrulatus venomA M C Pimenta, P Mansuelle, C R Diniz, et al.
Journal De Physiologie|January 1, 1984
Interaction of scorpion toxins with the sodium channelH Rochat, H Darbon, E Jover, et al.
The Journal of Rheumatology|August 1, 1992
Systemic lupus erythematosus presenting with myelofibrosisD Foley-Nolan, M F Martin, D Rowbotham, et al.
International Journal of Clinical Pharmacology Research|January 1, 1985
Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel antirheumatoid drugsJ S Dixon, H A Bird, M F Martin, et al.
British Journal of Rheumatology|October 1, 1988
The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapyT Pullar, S Peaker, M F Martin, et al.
Pageof 13